Answer
Jul 31, 2025 - 09:41 AM
Do you have the same question? Follow this Question
Jul 31, 2025 - 09:41 AM
We’ve provided several answers to questions related to Sotyktu (Deucravacitinib) , see some other helpful Q&A related to this product.
Question: What should patients inform their doctor about before starting this medication?
Answer: Patients should inform their doctor about any existing medical conditions or allergies. Transparency with healthcare providers ensures a safe treatment plan tailored to individual health needs.
Question: What conditions is this medication used to treat?
Answer: This medication is indicated for treating moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. It provides a targeted approach to managing psoriasis, offering relief for those with more severe cases.